| Dr Benjamin S Gozon Iii, MD | |
|
8518 W Capitol Dr, Milwaukee, WI 53222-1827 | |
| (414) 464-4888 | |
| (414) 464-1850 |
| Full Name | Dr Benjamin S Gozon Iii |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 8518 W Capitol Dr, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033170428 | NPI | - | NPPES |
| 34058300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 42976 (Wisconsin) | Primary |
| Entity Name | Benjamin S Gozon Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669433066 PECOS PAC ID: 6901852623 Enrollment ID: O20050325000356 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive data from a phase II clinical trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, a defining marker of ALCL. The data were presented today during an oral session at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, FL.
Genes are not destiny in determining whether an individual will suffer from depression, reports a new Northwestern Medicine study. Environment is a major factor, and nurture can override nature.
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
A team of researchers describes the presence of PDCoV strains in plasma samples of three Haitian children with acute undifferentiated febrile illness.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin S Gozon Iii, MD 8518 W Capitol Dr, Milwaukee, WI 53222-1827 Ph: (414) 464-4888 | Dr Benjamin S Gozon Iii, MD 8518 W Capitol Dr, Milwaukee, WI 53222-1827 Ph: (414) 464-4888 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive data from a phase II clinical trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, a defining marker of ALCL. The data were presented today during an oral session at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, FL.
Genes are not destiny in determining whether an individual will suffer from depression, reports a new Northwestern Medicine study. Environment is a major factor, and nurture can override nature.
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
A team of researchers describes the presence of PDCoV strains in plasma samples of three Haitian children with acute undifferentiated febrile illness.
› Verified 8 days ago
Dr. Philip A Nelson, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Spine Care Clinic At Plank Road, Milwaukee, WI 53226 Phone: 414-456-7199 | |
Dr. John R Mcguire, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Physical Medicine And Rehabilitation, Milwaukee, WI 53226 Phone: 414-805-7342 Fax: 414-805-7348 | |
Lindsay Gardenier, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9301 N 76th St, Milwaukee, WI 53223 Phone: 414-355-9300 | |
Dr. Brian Robertson-dick, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Avenue, Physical Medicine And Rehabilitation, Milwaukee, WI 53226 Phone: 414-805-7342 Fax: 414-805-7348 | |
Dr. Karie N Zach, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8700 W Watertown Plank Rd, Sports Medicine, Milwaukee, WI 53226 Phone: 414-805-7100 | |
Dr. Narayana Rao Parasu, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2901 W Kinnickinnic River Pkwy, Suite: 106, Milwaukee, WI 53215 Phone: 414-649-7708 Fax: 414-649-7028 |